CIK 0001108205 · Non-accelerated filer<br>Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043505116
- Phone
- 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-01-07 | BAYH SUSAN B Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-01-07 | Rubin Marc Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-01-07 | GREENACRE MARTYN D Director | Grant or award · Non-qualified stock option (right to buy) | +25,000 | 25,000 | ||
| 2011-01-07 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Qualified stock option (right to buy) | +93,492 | 93,492 | ||
| 2011-01-07 | Qian Changgeng VP, Research & Preclinical Dev | Grant or award · Non-qualified stock option (right to buy) | +31,508 | 31,508 | ||
| 2011-01-07 | PASSERI DANIEL R CEO and Director | Grant or award · Qualified stock option (right to buy) | +92,324 | 92,324 | ||
| 2011-01-07 | PASSERI DANIEL R CEO and Director | Grant or award · Non-qualified stock option (right to buy) | +107,676 | 107,676 | ||
| 2011-01-07 | NOEL MARK VP, Tech Management | Grant or award · Qualified stock option (right to buy) | +60,000 | 60,000 | ||
| 2011-01-07 | Keegan Mitchell Vice-President | Grant or award · Qualified stock option (right to buy) | +30,254 | 30,254 | ||
| 2011-01-07 | Keegan Mitchell Vice-President | Grant or award · Non-qualified stock option (right to buy) | +29,746 | 29,746 | ||
| 2011-01-07 | GRAY MICHAEL COO and CFO | Grant or award · Qualified stock option (right to buy) | +93,492 | 93,492 | ||
| 2011-01-07 | GRAY MICHAEL COO and CFO | Grant or award · Non-qualified stock option (right to buy) | +31,508 | 31,508 | ||
| 2010-12-10 | Rubin Marc Director | Purchase | +26,596 | $1.89 | $50K | 26,596 |
| 2010-10-04 | TOBIN JAMES R Director | Other disposition | −46,238 | 46,239 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −12,500 | 12,500 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −2,500 | 15,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −12,500 | 27,500 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −75,000 | 102,500 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −2,500 | 105,000 | ||
| 2010-10-04 | TOBIN JAMES R Director | Other disposition · Non-qualified stock option (right to buy) | −62,500 | 167,500 |
Page 23 of 29 · 564 trades